Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis입원 예방을 위한 COVID-19 외래 환자 관리를 위한 Fluvoxamine: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-04-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI all-cause hospitalization Analysis antivirals association Bayesian Bia clinical clinical trials conducted COVID-19 data extraction demographics doses Effectiveness Efficacy estimate estimates evaluate Evidence fluvoxamine Health Organization Hospitalization inclusion criteria individual management Meta-analysis moderate monoclonal antibody monoclonal antibody therapy Neutral outcome Outpatient outpatients Participants patients Placebo Prevent Probability random effect random-effect randomized clinical trial randomized trial ranged reduced registry review risk risk ratio SARS-CoV-2 scenario synthesis systematic review therapy Trial trials variety with COVID-19 World Health Organization [DOI] 10.1001/jamanetworkopen.2022.6269 PMC 바로가기 [Article Type] Meta-Analysis
Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub-Saharan Africa: A prospective longitudinal study사하라 사막 이남 아프리카의 상황에서 COVID-19 환자의 SARS-CoV-2에 대한 항체 반응의 종단 프로필: 전향적 종단 연구Article Published on 2022-03-232022-09-11 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, [키워드] African agreement antibody Antibody Response asymptomatic patient asymptomatic patients Cohort collected comprehensive evaluation COVID-19 cases COVID-19 patient detectable diagnosis of COVID-19 enrolled Enrollment epidemiological studies Factor failure Follow-up heterogeneous responses IgG IgM immunoassay implementation increase increases in lateral flow LFIAs longitudinal Longitudinal assessment median median time no difference NPV onset of symptoms Patient patients with COVID-19 PCR-confirmed COVID-19 patient plasma sample plasma samples positive Positive predictive value PPV Predictive value Prospective Study ranged reached reduced Research SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody scenario Seroconversion seroconversion time seroconvert seroconverted Serological testing serology Seroprevalence significantly specificity symptom onset symptomatic case symptomatic cases tested vaccine responses [DOI] 10.1371/journal.pone.0263627 PMC 바로가기 [Article Type] Article
Modelling the potential health and economic benefits of reducing population sitting time in AustraliaRandomized Controlled Trial Published on 2022-03-192022-10-04 Journal: The international journal of behavioral nutrition and physical activity [Category] 임상, [키워드] age Analysis benefit can be used Care changes in Chronic diseases Colorectal cancer consequence Cost-of-illness COVID-19 pandemic disease disease incidence estimate Evidence feasible FIVE Health health benefits healthcare Healthcare cost improvement incidence indicate Intervention literature review Markov meta-analyses modelling Mortality outcome per day Policy predict Prevalence prevalent public health randomised controlled trial reducing reductions in resource risk scenario Sedentary behaviour. sedentary time Stand stroke Strong survey turn type 2 diabetes Victoria was reduced Welfare [DOI] 10.1186/s12966-022-01276-2 PMC 바로가기 [Article Type] Randomized Controlled Trial
In-Flight Transmission of a SARS-CoV-2 Lineage B.1.617.2 Harbouring the Rare S:E484Q Immune Escape MutationSARS-CoV-2 계통의 기내 전파 B.1.617.2 희귀 S:E484Q 면역 탈출 돌연변이 보유Article Published on 2022-02-282022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Analysis B.1.617.2 Combination Community COVID-19 pandemic Delta delta. described detectable E484Q escape Genetic genomic Immune escape individual Infection Lineage lineages Mutation omicron Point mutation positive Prevalence Probability SARS-CoV-2 scenario sequenced Seven transmission rate variant [DOI] 10.3390/v14030504 PMC 바로가기 [Article Type] Article
Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia호주에서 SARS-CoV-2 델타 변종 전파 시나리오 시뮬레이션Article Published on 2022-02-242022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] agent-based model Analysis B.1.617.2 Case isolation Community computational epidemiology COVID-19 Delta Delta (B.1.617.2) variant delta variant Epidemic expected fatality feasible healthcare healthcare burden Healthcare system home quarantine incidence indicated Interaction nation outbreak per day predicted quantified reduced SARS-CoV-2 scenario social distancing suggested vaccination variant variant of SARS-CoV-2 [DOI] 10.3389/fpubh.2022.823043 PMC 바로가기 [Article Type] Article
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020Article Published on 2022-02-142022-10-29 Journal: Scientific Reports [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] affected age Analysis assessment calculated collected conducted COVID-19 COVID-19 disease death deaths disease Diseases groups Health Health care highest implication India input men occurred pandemic proportion recorded Region reported required responsible scenario standard life Support the disease unique Washington women [DOI] 10.1038/s41598-022-06505-z PMC 바로가기 [Article Type] Article
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle푸린을 표적으로 하는 실행 가능한 대안 전략은 SARS-CoV-2 감염 주기를 방해합니다Research Article Published on 2022-02-092022-09-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] ACE2 Activation addition angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antibodies antibody Antibody Response applicability approach binding blockade Cell cellular entry chain cleavage competing coronavirus COVID-19 Critical cycle described disease pathology DNA domain effective Efficacy epitope flexible linker furin Health Hospitalization Host host cell host cells host protease human lung cell human lung cells IgG1 Immunological memory in viral independent Infection infection cycle infections interfere lung cells membrane fusion Mortality occur overcome peptide plug processing producing protease Proteases proteolytic activation Proteolytic processing public health threat remained remains uncertain residue RNA SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 variants SARS-CoV-2 viral particles scenario secretory pathway solution spike glycoprotein Spike protein Strategy subsequent targeted therapy targeting the spike protein Transmission Vaccine Viral viral entry Viral transmission virus virus-producing cell virus-producing cells viruses [DOI] 10.1128/spectrum.02364-21 PMC 바로가기 [Article Type] Research Article
COVID-19 detection using chest X-ray images based on a developed deep neural network개발된 심층신경망 기반 흉부 X선 영상을 이용한 코로나19 탐지Article Published on 2022-02-012022-09-11 Journal: Slas Technology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Accuracy added addition approaches assist assumption Bacterial chest X-ray Chest X-ray image COVID-19 database databases Diagnosis effective expressed feature Final Human Infectious disease investigated lung Mortality Neural New coronavirus Pneumonia radiologist Radiologists raw data robust scenario solution Spread tested the disease time virus [DOI] 10.1016/j.slast.2021.10.011 PMC 바로가기 [Article Type] Article
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAsPDE4 억제제인 Tanimilast는 SARS-CoV-2 ssRNA에 의한 전염증성 수지상 세포 활성화를 둔화시킵니다Immunology Published on 2022-01-242022-09-11 Journal: Frontiers in Immunology [Category] 치료법, [키워드] acquisition activate activated DCs Activation anti-inflammatory drug approved atopic dermatitis blocked CCL3 CCR7 CD4 CD8 CD83 CD86 cDCs chemokine chemokines CHF6001 clinical development Clinical studies COPD COVID-19 CXCL10 CXCL9 cytokine Cytokines DCs demonstrated dendritic cell did not reduce disease dysregulation genomic homing receptor hyperinflammation IL-12 IL-6 immune dysregulation immune response immunomodulatory immunomodulatory drug immunomodulatory drugs impair Inflammatory inflammatory conditions Inhaled inhibitor International Lymph node lymph node homing marker maturation MHC-I MHC-II modulate non-proprietary name pDCs phenotype phosphodiesterase phosphodiesterase 4 (PDE4) inhibitors pro-inflammatory pro-inflammatory cytokine pro-inflammatory cytokines proinflammatory cytokines proliferation psoriasis receptor SARS-CoV-2 SARS-COV-2 infection scenario selective skewed ssRNA steroid T cell T cells Tanimilast Th2 TNF-α treat Treatment type I IFNs [DOI] 10.3389/fimmu.2021.797390 PMC 바로가기 [Article Type] Immunology
Impact of pre-event testing and quarantine on reducing the risk of COVID-19 epidemic rebound: a modelling studyCOVID-19 전염병 반동의 위험 감소에 대한 사전 이벤트 테스트 및 검역소의 영향 : 모델링 연구Research Article Published on 2022-01-242022-09-10 Journal: BMC Infectious Diseases [Category] SARS, 치료기술, [키워드] adjusted affected Against All participants assumed benefit caused Chain Reaction China Community confirmed case Contact Coverage COVID-19 COVID-19 epidemic effective Epidemic examined feasible followed by growth Guangdong Impact increase Infection infections influx International Intervention Large-scale event lead Local mathematical mathematical model Mathematical modelling new infections occur participant Participants participated PCR polymerase chain polymerase chain reaction Prevalence prohibition quarantine reducing Result risk risk of COVID-19 SARS-CoV-2 SARS-CoV-2 transmission scenario Sensitivity analyses supplementary material Testing the epidemic the SARS-CoV-2 Travel Universal virus transmission [DOI] 10.1186/s12879-021-06963-2 PMC 바로가기 [Article Type] Research Article